Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [ ¹⁷⁷ Lu]Lu-PSMA-617.

Autor: Muniz M; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota; munizrincon.miguel@mayo.edu., Sartor O; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota.; Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, Minnesota., Orme JJ; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Koch RM; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Rosenow HR; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Mahmoud AM; Department of Radiation Oncology, Kansas University Medical Center, Kansas City, Kansas., Andrews JR; Department of Urology, Mayo Clinic, Phoenix, Arizona., Kase AM; Department of Medical Oncology, Mayo Clinic, Jacksonville, Florida., Riaz IB; Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, Arizona., Belge Bilgin G; Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, Minnesota., Thorpe MP; Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, Minnesota., Kendi AT; Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, Minnesota., Johnson GB; Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, Minnesota.; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Ravi P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; and., Kwon ED; Department of Urology, Mayo Clinic, Rochester, Minnesota., Childs DS; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota.

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Dec 03; Vol. 65 (12), pp. 1932-1938. Date of Electronic Publication: 2024 Dec 03.